172949-39-2

Upstream product

• 41546-30-9 β-L-arabinose 

Downstream Products

• 172949-41-6 1,2-O-Isopropylidene-5-O-triphenylmethyl-α-L-ribofuranose 
• 171721-12-3 1,2-di-O-isopropylidene-3,5-di-O-benzoyl-α-L-ribofuranose 
• 917222-29-8 Benzyl-[1-((3aS,5S,6R,6aS)-6-benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-meth-(E)-ylidene]-amine 
• 528593-81-9 (2S,3S,4S,5R)-1-Benzyl-4-benzyloxy-2-methyl-piperidine-3,5-diol 
• 145772-63-0 (3aS,5R,6R,6aS)-6-Benzyloxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxole-5-carbaldehyde 
• 449729-69-5 1,6-dideoxy-L-nojirimycin 
• 391201-57-3 [(3aS,5S,6R,6aS)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methanol 
• 528593-79-5 (3aS,5S,6R,6aS)-6-Benzyloxy-2,2-dimethyl-5-trityloxymethyl-tetrahydro-furo[2,3-d][1,3]dioxole 
• 172949-40-5 1,2-O-Isopropylidene-5-O-triphenylmethyl-α-L-threo-pentofuranose-3-ulose 

Relevant academic research and scientific papers

First stereocontrolled synthesis and biological evaluation of 1,6-dideoxy-L-nojirimycin

The first synthesis of 1,6-dideoxy-L-nojirimycin in enantiomerically pure form has been achieved in nine steps from L-xylose in an overall yield of 15%. The biological activity of this compound as a glycosidase inhibitor provided useful information on str